
Sarcopenia, defined by progressive loss of skeletal muscle mass, strength, and function, is a major contributor to frailty, falls, and disability in older adults. Resistance exercise training is the most evidence-based intervention; protein optimisation and leucine supplementation support muscle anabolism. Myostatin inhibitors and selective androgen receptor modulators are among the pharmacological approaches in clinical development.
Loading articles...
